Futura Medical PLC Remuneration of Non-Executive Directors and TVR (8957M)
11 January 2019 - 10:01PM
UK Regulatory
TIDMFUM
RNS Number : 8957M
Futura Medical PLC
11 January 2019
Remuneration of Non-Executive Directors and Total Voting
Rights
11 January 2019
Futura Medical plc (AIM: FUM) (the "Company"), a pharmaceutical
company developing a portfolio of innovative products for sexual
health and pain relief, announces the issue of 76,828 new ordinary
shares of 0.2 pence each ("Ordinary Shares") in respect of the 2018
remuneration of its Non-Executive Directors.
In accordance with the terms of their service agreements, the
Non-Executive Directors receive approximately 30 per cent of their
remuneration in the form of Ordinary Shares. For 2018, these were
issued at 25.10 pence per share, being the average closing
mid-market price of the last 10 trading days of 2017 (as announced
via RNS on 2 January 2018).
The 76,828 new ordinary shares shall rank pari passu with the
existing issued Ordinary Shares of the Company and have been issued
as follows:
Director Number of Ordinary Shares Total number of ordinary shares Percentage of the Company's
issued for 2018 remuneration held resulting issued share capital
John Clarke 57,250 256,226 0.13%
Jonathan Freeman 19,578 90,621 0.04%
Application has been made to the London Stock Exchange and it is
anticipated that trading of the new ordinary shares will commence
on AIM at 8:00am on 16 January 2019.
Immediately following the above issue, the Company will have
204,660,267 ordinary shares in issue, each carrying one voting
right. Since the Company currently holds no shares in treasury, the
total number of voting rights in the Company is therefore
204,660,267 and this figure may be used by Shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change in their
interest in, the share capital of the Company under the FCA's
Disclosure Guidance and Transparency Rules.
The shares element of the Non-Executive Directors' remuneration
for 2019 will be awarded at 6.01 pence per Ordinary Share, being
the average closing mid-market price of the last 10 trading days of
2018. The Non-Executive Directors will receive these shares in
January 2020.
Further details are contained within the notifications below,
made in accordance with Article 19 of the EU Market Abuse
Regulation 596/2014. Full details of the Non-Executive Directors'
remuneration will be included in the Company's Annual Report &
Accounts.
ENDS
For further information please contact:
Futura Medical plc
James Barder, Chief Executive
Angela Hildreth, Finance Director and COO
Email: Investor.relations@futuramedical.com
Tel: +44 (0) 1483 685 670
Nominated Adviser and Broker:
N+1 Singer
Aubrey Powell/ Ben Farrow (Corporate Finance)
Tom Salvesen/ Mia Gardner (Corporate Broking)
Tel: +44 (0) 20 7496 3000
For media enquiries please contact:
Optimum Strategic Communications
Mary Clark/ Hollie Vile/ Ellie Blackwell
Email: futuramedical@optimumcomms.com
Tel: +44 (0) 203 950 9144
Notes to editors
About Futura Medical plc
Futura Medical plc (AIM: FUM), is a pharmaceutical company
developing a portfolio of innovative products based on its
proprietary, transdermal DermaSys(R) drug delivery technology.
These products are optimised for clinical efficacy, safety,
administration and patient convenience and are developed for the
prescription and consumer healthcare markets as appropriate.
Current therapeutic areas are sexual health, including erectile
dysfunction, and pain relief. Development and commercialisation
strategies are designed to maximise product differentiation and
value creation whilst minimising risk.
Futura is based in Guildford, Surrey, and its shares trade on
the AIM market of the London Stock Exchange.
www.futuramedical.com
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name John Clarke
------------------------------ -----------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
25.10 pence 57,250
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 11 January 2019
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Jonathan Freeman
------------------------------ -----------------------------------
2 Reason for the notification
-------------------------------------------------------------------
a) Position/status Director/ PDMR
------------------------------ -----------------------------------
b) Initial notification Initial notification
/Amendment
------------------------------ -----------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-------------------------------------------------------------------
a) Name Futura Medical plc
------------------------------ -----------------------------------
b) LEI 21380053QLT46UNV2303
------------------------------ -----------------------------------
4 Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transactions
have been conducted
-------------------------------------------------------------------
a) Description of the
financial instrument, Ordinary shares of 0.2p each
type of instrument
GB0033278473
Identification code
------------------------------ -----------------------------------
b) Nature of the transaction Issue of shares
------------------------------ -----------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
25.10 pence 19,578
----------
------------------------------ -----------------------------------
d) Aggregated information
- Aggregated volume
Not applicable
- Price
------------------------------ -----------------------------------
e) Date of the transaction 11 January 2019
------------------------------ -----------------------------------
f) Place of the transaction Outside of trading venue
------------------------------ -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHKMGMMGMRGLZM
(END) Dow Jones Newswires
January 11, 2019 06:01 ET (11:01 GMT)
Futura Medical (LSE:FUM)
Historical Stock Chart
From Apr 2024 to May 2024
Futura Medical (LSE:FUM)
Historical Stock Chart
From May 2023 to May 2024